Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$96.4M
-13.0% from 2023
Prescriptions
5,533
$17,426.97 per claim
Patients
1,723
1,595 prescribers
Total spending, 2024
$96.4M
$55,962.53 per patient
Medicare prescription drug plans paid $96.4M for Stivarga in 2024, for 5,533 prescriptions and refills to 1,723 patients (down 13.0% from 2023). The average cost per claim was $17,426.97.
California had the highest Medicare cost for Stivarga in 2024: $13.4M for 778 claims, followed by Texas ($9.2M).
Kee Y Shum, internal medicine in Flushing, NY, had the highest Medicare cost for Stivarga in 2024: 26 claims costing $594K.
Stivarga is made by Bayer Aktiengesellschaft (BAYN.DE), listed in the Medicare spending data as Bayer,Pharm Div.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Kee Y Shum Flushing, NY | Internal Medicine | 26 | Under 11 | $594K |
| Kirtan N Koticha Shreveport, LA | Hematology-Oncology | 24 | Under 11 | $533K |
| Julie H Rowe |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,043 | 7,186 | 2,287 | $118.5M |
| 2023 | 1,812 | 6,327 | 2,000 | $110.8M |
| 2024 | 1,595 | 5,533 | 1,723 | $96.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 23 |
| Under 11 |
| $482K |
| Vi K Chiu Los Angeles, CA | Hematology-Oncology | 20 | Under 11 | $454K |
| Shreyaskumar R Patel Houston, TX | Internal Medicine | 17 | Under 11 | $433K |
| Thomas B Sneed Little Rock, AR | Hematology-Oncology | 19 | Under 11 | $406K |
| Manuel A Santiago San Antonio, TX | Hematology-Oncology | 21 | Under 11 | $380K |
| Seth D Cohen West Long Branch, NJ | Hematology-Oncology | 21 | Under 11 | $365K |
| Chaoyuan Kuang Bronx, NY | Medical Oncology | 25 | Under 11 | $347K |
| Curtis R Chong Palo Alto, CA | Medical Oncology | 23 | Under 11 | $344K |
| Thomas W Ratliff Germantown, TN | Hematology-Oncology | 20 | Under 11 | $343K |
| Sebastien S Kairouz Decatur, IL | Medical Oncology | 14 | Under 11 | $337K |
| John M Strother Salem, OR | Hematology-Oncology | 16 | Under 11 | $333K |
| Dhwani Y Pandya Wilkes Barre, PA | Medical Oncology | 14 | Under 11 | $327K |
| Venkata K Parsa Fort Myers, FL | Hematology-Oncology | 14 | Under 11 | $317K |
| John P Schwerkoske Encinitas, CA | Hematology-Oncology | 14 | Under 11 | $306K |
| Afshin E Gabayan Beverly Hills, CA | Hematology-Oncology | 18 | Under 11 | $305K |
| Melvin P Palalay Honolulu, HI | Hematology-Oncology | 13 | Under 11 | $304K |
| Elizabeth A Bowhay-Carnes San Antonio, TX | Hematology-Oncology | 15 | Under 11 | $304K |
| Rangaswamy Govindarajan Little Rock, AR | Hematology-Oncology | 13 | Under 11 | $303K |
| Steven Bialick Deerfield Beach, FL | Internal Medicine | 13 | Under 11 | $301K |
| Iloabueke G Chineke Casper, WY | Hematology-Oncology | 13 | Under 11 | $300K |
| Mina S Hanna Albert Lea, MN | Medical Oncology | 12 | Under 11 | $285K |
| Nicolas A Villanueva Honolulu, HI | Hematology-Oncology | 17 | Under 11 | $285K |
| Anthony P Conley Houston, TX | Medical Oncology | 15 | Under 11 | $277K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Bayer,Pharm Div BAYN.DE | 5,533 | $96.4M |